ATE232740T1 - Medikament zur linderung von schmerzen und zur förderung der entfernung von konkrementen bei urolithiasis - Google Patents

Medikament zur linderung von schmerzen und zur förderung der entfernung von konkrementen bei urolithiasis

Info

Publication number
ATE232740T1
ATE232740T1 AT96939325T AT96939325T ATE232740T1 AT E232740 T1 ATE232740 T1 AT E232740T1 AT 96939325 T AT96939325 T AT 96939325T AT 96939325 T AT96939325 T AT 96939325T AT E232740 T1 ATE232740 T1 AT E232740T1
Authority
AT
Austria
Prior art keywords
drug
urolithiasis
promoting
removal
relieving pain
Prior art date
Application number
AT96939325T
Other languages
English (en)
Inventor
Masuo Akahane
Yoshitaka Tomiyama
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Application granted granted Critical
Publication of ATE232740T1 publication Critical patent/ATE232740T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT96939325T 1995-11-30 1996-11-29 Medikament zur linderung von schmerzen und zur förderung der entfernung von konkrementen bei urolithiasis ATE232740T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34659995 1995-11-30
PCT/JP1996/003494 WO1997019700A1 (fr) 1995-11-30 1996-11-29 Nouveau medicament pour attenuer la douleur et favoriser l'elimination des calculs lies a l'urolithiase

Publications (1)

Publication Number Publication Date
ATE232740T1 true ATE232740T1 (de) 2003-03-15

Family

ID=18384525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96939325T ATE232740T1 (de) 1995-11-30 1996-11-29 Medikament zur linderung von schmerzen und zur förderung der entfernung von konkrementen bei urolithiasis

Country Status (10)

Country Link
US (2) US6410560B1 (de)
EP (1) EP0872246B1 (de)
KR (1) KR19990071800A (de)
AT (1) ATE232740T1 (de)
AU (1) AU7639796A (de)
DE (1) DE69626312T2 (de)
DK (1) DK0872246T3 (de)
ES (1) ES2195021T3 (de)
PT (1) PT872246E (de)
WO (1) WO1997019700A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID24062A (id) * 1997-07-25 2000-07-06 Kissei Pharmaceutical Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing
US20040097996A1 (en) 1999-10-05 2004-05-20 Omnisonics Medical Technologies, Inc. Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode
WO2004064835A1 (en) * 2003-01-17 2004-08-05 Neurosearch A/S Use of ion channel modulating agents for treating pain
US7794414B2 (en) 2004-02-09 2010-09-14 Emigrant Bank, N.A. Apparatus and method for an ultrasonic medical device operating in torsional and transverse modes
EP1955707A4 (de) * 2005-11-28 2010-09-01 Kissei Pharmaceutical Pharmazeutische zusammensetzung zur prävention oder behandlung von neurogenen schmerzen
US10267796B2 (en) * 2010-10-25 2019-04-23 The Procter & Gamble Company Screening methods of modulating adrenergic receptor gene expressions implicated in melanogenesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25150A (en) * 1986-06-05 1991-03-13 Ciba Geigy Ag Novel pharmaceutical preparation for topical application

Also Published As

Publication number Publication date
KR19990071800A (ko) 1999-09-27
DK0872246T3 (da) 2003-06-10
ES2195021T3 (es) 2003-12-01
DE69626312D1 (de) 2003-03-27
AU7639796A (en) 1997-06-19
US6410560B1 (en) 2002-06-25
DE69626312T2 (de) 2004-01-22
EP0872246A4 (de) 1999-03-24
PT872246E (pt) 2003-07-31
US6376513B1 (en) 2002-04-23
EP0872246B1 (de) 2003-02-19
WO1997019700A1 (fr) 1997-06-05
EP0872246A1 (de) 1998-10-21

Similar Documents

Publication Publication Date Title
HUT59313A (en) Process for producing pharmaceutical composition comprising flupirtin as active ingredient and suitable for combatting muscular tensions
NO972972L (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
DE69630947D1 (de) Mittel zur schmerzbehandlung
NO20001754L (no) Prostaglandinagonister og anvendelse derav for behandling av benforstyrrelser
PT861081E (pt) Utilizacao de epinastina para o tratamento de dores
DE59410125D1 (de) Gerät zur schmerztherapie und/oder zur beeinflussung des vegetativen nervensystems
EP0844008A4 (de) Vorrichtung die gebraucht wird bei laserbehandlung von biologischem gewebe oder desgleichen
BR9711225A (pt) Composi-{es de propentofilina transd-rmica para o tratamento do mal de alzheimer
DE69620691T2 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
ATE232740T1 (de) Medikament zur linderung von schmerzen und zur förderung der entfernung von konkrementen bei urolithiasis
EP0744176A3 (de) Arzneimittel zur Hemmung von Knochenschwund
DE9305147U1 (de) Trainingsgerät zur Behandlung von an Wahrnehmungsstörungen leidenden Patienten
PT925039E (pt) Aparelhos para tratamento de ortopedia funcional dento facial e parodontologia
ITRM960827A0 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
DE69510933D1 (de) Amidderivate und ihre therapeutische anwendung
NO982562D0 (no) Sammensetning for behandling av smerte
CA2238621A1 (en) Novel drug for relieving pain and promoting the removal of calculi in urolithiasis
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
FR2726184B1 (fr) Appareil de reeducation de la colonne vertebrale humaine
EP1440163A4 (de) Verfahren und zusammensetzungen zur behandlung und diagnose von schmerzerkrankungen unter verwendung von 46566
DE9411818U1 (de) Medizinisches Gerät zur Behandlung von rheumatischen Schmerzen
EP1440169A4 (de) Verfahren und zusammensetzungen zur behandlung und diagnose von schmerzspezifischen störungen unter verwendung von 57749
FR2707165B1 (fr) Application des taxoides au traitement de maladies d'origine parasitaire .
ATE337745T1 (de) Behandlungsinstrument für die medizinische oder zahnmedizinische behandlung von kindern
DE59611380D1 (de) Behandlungsinstrument für die medizinische oder zahnmedizinische behandlung von kindern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0872246

Country of ref document: EP

REN Ceased due to non-payment of the annual fee